Human trafficking, cyber security, the decline in court funding and gender equity issues in the legal profession are the focus of just some of the legal programs at the American Bar Association Annual Meeting August 8-13 in San Francisco where Avnet, Inc. (NYSE:AVT), Vice President and General Counsel for the Americas Cheree McAlpine will be presenting on “The Real Deal.” The panel, “GC’S Give the Real Deal: A Candid Discussion about Best Practices, Value and Silicon Valley,” will be held on August 9th.
Along with several other legal professionals, McAlpine will participate in a panel discussion on privacy law, high-tech law issues, emerging trends relative to in-house and outside counsel relations, and will provide an overview of best practices. Likewise, the panel will discuss what law departments and outside counsel are actually doing to demonstrate and provide more value. Finally, the panel will provide anecdotes to empower both in-house and outside counsel to implement tools to enhance their practice and success.
“Sharing best practices is probably one of the most important activities for any professional, especially those of us in law,” said McAlpine. “Law is a dynamic field and issues emerge sometimes almost overnight requiring all of us to be at the top of our game in order to provide more value to the clients we represent. During the conference we will be discussing the everyday challenges we all face and share our key lessons learned.”
As a 19-year veteran of the Silicon Valley legal community, McAlpine brings significant industry knowledge in corporate law, mergers and acquisitions, and intellectual property transactions to her position at Avnet. She most recently served as vice president and general counsel of Wyse Technology, Inc., a cloud client computing company, where she was responsible for worldwide legal affairs. In May 2012, she led the legal aspects of the sale of the company to Dell Computers. While at Wyse, McAlpine also helped to increase the company’s patent portfolio by more than 300 percent, which had a direct impact on the company’s valuation.
The National Diversity Council recently selected McAlpine to receive its 2013 Most Powerful and Influential Women in California Award. McAlpine was recognized at the 2013 California Diversity and Leadership Conference on April 18, 2013. This accolade honors high-ranking female executives from a variety of industries who have demonstrated leadership excellence, a record of accomplishments, impact on the direction of their organizations, visibility in the community and commitment to the highest ethical standards.
About Avnet, Inc.
Avnet, Inc. (NYSE: AVT), a Fortune 500 company, is one of the largest distributors of electronic components, computer products and embedded technology serving customers globally. Avnet accelerates its partners' success by connecting the world's leading technology suppliers with a broad base of customers by providing cost-effective, value-added services and solutions. For the fiscal year ended June 29, 2013, Avnet generated revenue of $25.5 billion. For more information, visit www.avnet.com.
Avnet and the Avnet logo are trademarks of Avnet, Inc. in the United States and other countries. All other brands and trade names are trademarks or registered trademarks, and are the properties of their respective owners. Avnet disclaims any proprietary interest in marks other than its own.
Joal Redmond, 480-643-5528
Vice President, Public Relations
|NPS Pharmaceuticals Reports Gattex STEPS 2 Study to be Presented at American College of Gastroenterology Meeting ()|
|Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX® For The Treatment Of Dupuytren's Contracture (2013/10/7)|
|Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo (2014/3/17)|
|ZIOPHARM Presents Preclinical Data at AACR Annual Meeting Supporting Controlled DNA-based IL-12 Therapy for Brain Cancer (2014/4/8)|
|LDR Announces Presentation of Mobi-C(R) Cervical Disc Four Year Clinical Results at the North American Spine Society Annual Meeting (2013/10/25)|
|BELVIQ® (lorcaserin HCl) CIV Data to be Presented at American Heart Association 2013 Scientific Sessions ()|
|JetPay Corporation Shows New Products at Transact 14: The Electronic Transaction Association’s Annual Meeting in Las Vegas (2014/4/3)|
|ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 55th ASH Annual Meeting and Exposition (2013/12/3)|
|Bristol-Myers Squibb to Present Range of New Hepatitis C Data at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting ()|
|Stemline Therapeutics Announces Presentation of SL-501 Preclinical Efficacy Data in TKI-Resistant CML at the Annual Meeting of the American Association of Cancer Research (AACR) (2014/4/1)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.